Indication

Prevention of breast cancer in high risk women

Prevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population. Read more about Prevention of breast cancer in high risk women

32 drugs 26 manufacturers

Advertisement

Drugs that treat it

Common Prevention of breast cancer in high risk women therapies.

Showing 28–32 of 32 drugs

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
BRYANT RANCH PR

RALOXIFENE HCL

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
AUROBINDO PHARM

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
AUROBINDO PHARM

RALOXIFENE HCL

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
APHENA PHARMA S

RALOXIFENE HCL

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
MODAVAR PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Prevention of breast cancer in high risk women preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of breast cancer in high risk women.

Prevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population.

This targeted demographic typically includes women with predisposing germline mutations, a strong family history of breast or ovarian cancer, prior high-risk histologic lesions such as atypical hyperplasia or lobular carcinoma in situ, or an elevated multi-factor risk score determined by validated predictive models.

Pathophysiologically, the state involves an altered mammary microenvironment driven by accumulated genetic instability, high-penetrance DNA-repair deficiencies, or prolonged estrogen-mediated proliferative signaling within glandular breast tissue.

Intervention in this setting seeks to disrupt oncogenic transformation and suppress early cellular progression before invasive malignant disease occurs.

Personalize your experience

Follow Prevention of breast cancer in high risk women and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it